RULE NO: RULE TITLE
64B16-27.500: Negative Drug Formulary
PURPOSE AND EFFECT: The Board proposes the rule amendment to consider whether levothyroxine sodium should remain on the negative formulary list.
SUBJECT AREA TO BE ADDRESSED: Negative Drug Formulary
SPECIFIC AUTHORITY: 465.005, 465.025(6) FS., Ch. 2001-146, Laws of Florida.
LAW IMPLEMENTED: 465.025(6) FS., Ch. 2001-146, Laws of Florida.
IF REQUESTED IN WRITING AND NOT DEEMED UNNECESSARY BY THE AGENCY HEAD, A RULE DEVELOPMENT WORKSHOP WILL BE NOTICED IN THE NEXT AVAILABLE FLORIDA ADMINISTRATIVE WEEKLY.
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE DEVELOPMENT AND A COPY OF THE PRELIMINARY DRAFT, IF AVAILABLE, IS: Rebecca Poston, Executive Director, Board of Pharmacy/MQA, 4052 Bald Cypress Way, Bin #C04, Tallahassee, Florida 32399-3254

THE PRELIMINARY TEXT OF THE PROPOSED RULE DEVELOPMENT IS NOT AVAILABLE.